j contemp med

Journal of Contemporary Medicine

2667-7180

Rabia YILMAZ

Internal Diseases

İç Hastalıkları

"Relationship between Increased Epicardial Fat Tissue and Aortic Dilatation: may be an Indicator of Hypertension Complications"

"Epikard Yağ Dokusu Artışı ile Aort Genişlemesi Arasındaki İlişki: Hipertansiyon Komplikasyonlarının Göstergesi Olabilir"

https://orcid.org/0000-0003-2689-4287

Yücel

Nurullah

SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, HAMİDİYE ULUSLARARASI TIP FAKÜLTESİ, TEMEL TIP BİLİMLERİ BÖLÜMÜ, ANATOMİ ANABİLİM DALI

https://orcid.org/0000-0001-5058-3513

Aygun

Tayfun

GİRESUN ÜNİVERSİTESİ, ŞEBİNKARAHİSAR SOSYAL BİLİMLER MESLEK YÜKSEKOKULU, TIBBİ HİZMETLER VE TEKNİKLER BÖLÜMÜ, İLK VE ACİL YARDIM PR.

https://orcid.org/0000-0002-6815-2540

Düz

Meryem Esma

ANKARA MEDİPOL UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF BASIC MEDICAL SCIENCES (MEDICINE), DEPARTMENT OF ANATOMY (MEDICINE)

https://orcid.org/0000-0002-5027-6756

Hekimoğlu

Gulam

SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, HAMİDİYE ULUSLARARASI TIP FAKÜLTESİ, TEMEL TIP BİLİMLERİ BÖLÜMÜ, HİSTOLOJİ VE EMBRİYOLOJİ ANABİLİM DALI

https://orcid.org/0000-0001-8740-1429

Huyut

Mustafa Ahmet

SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, İSTANBUL PROF. DR. CEMİL TAŞÇIOĞLU ŞEHİR SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ, KARDİYOLOJİ ANABİLİM DALI

https://orcid.org/0000-0001-9577-388X

Kızılay

Mehmet

SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, İSTANBUL DR. SİYAMİ ERSEK GÖĞÜS KALP VE DAMAR CERRAHİSİ SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ, KARDİYOLOJİ ANABİLİM DALI

https://orcid.org/0000-0002-6852-3030

Şeker

Muzaffer

NECMETTİN ERBAKAN ÜNİVERSİTESİ, MERAM TIP FAKÜLTESİ, TEMEL TIP BİLİMLERİ BÖLÜMÜ, ANATOMİ ANABİLİM DALI

11 30 2023

13 6 1109 1116 09 27 2023 11 19 2023

2011

Journal of Contemporary Medicine

AbstractBackground/Aims: Epicardial fat tissue (EFT) refers to the adipose tissue on the myocardium's surface and beneath the visceral pericardium. It participates in the endocrine system as well as the myocardium's energy metabolism. This study aimed to investigate the potential of EFT as a noninvasive marker for hypertension (HT) complications associated with aortic dilatation.Methods: The study's healthy control (HC) group consisted of 70 patients with normal blood pressure and the HT group consisted of 82 patients with higher blood pressure. HT groups were separated into four categories, prehypertensive, stage 1, stage 2, and stage 3. EFT was assessed by two-dimensional echocardiography from the parasternal long axis and compared between the HC and the HT groups. Results: The EFT thickness in the HT group was considerably higher than in the HC (5.7±1.9 vs 4.0±1.3, p

ÖzArka plan/Amaç: Epikardiyal yağ dokusu (EFT), miyokardın yüzeyinde ve visseral perikardın altındaki yağ dokusunu ifade eder. Endokrin sisteme ve miyokardın enerji metabolizmasına katılır. Bu çalışma, aort dilatasyonu ile ilişkili hipertansiyon (HT) komplikasyonları için EFT'nin non invaziv bir belirteç olma potansiyelini araştırmayı amaçlamıştır.Yöntem: Çalışmanın sağlıklı kontrol (HC) grubunu tansiyonu normal olan 70 hasta, HT grubunu ise tansiyonu yüksek olan 82 hasta oluşturdu. HT grupları prehipertansif, evre 1, evre 2 ve evre 3 olmak üzere dört kategoriye ayrıldı. EFT parasternal uzun eksenden iki boyutlu ekokardiyografi ile değerlendirilerek HC ve HT grupları arasında karşılaştırıldı.Bulgular: HT grubunda EFT kalınlığı HC'ye göre oldukça yüksekti (5,7±1,9 vs 4,0±1,3, p

hypertension biomarker epicardial fat tissue complications morphometry

hipertansiyon morfometri biyobelirteç epikardiyal yağ dokusu komplikasyonlar

1. Bolívar JJ. Essential hypertension: an approach to its etiology and neurogenic pathophysiology. Int J Hypertens 2013; 2013: 547809.

2. Warren HR, Evangelou E, Cabrera CP, et al. Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk. Nat Genet 2017; 49(3): 403-415.

3. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet 2017; 389(10064): 37-55.

4. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365(9455): 217-23.

5. Thom S. Arterial structural modifications in hypertension. Effects of treatment. Eur Heart J 1997; 18 Suppl E, E2–E4.

6. Martinez-Quinones P, McCarthy CG, Watts SW, et al. Hypertension Induced Morphological and Physiological Changes in Cells of the Arterial Wall. Am J Hypertens 2018; 31(10): 1067–1078.

7. Laurent S, Boutouyrie P. The structural factor of hypertension: large and small artery alterations. Circ Res 2015; 116(6): 1007–1021.

8. Lough ME. Cardiovascular anatomy and physiology. Critical Care Nursing-E-Book: Diagnosis and Management 2013; 200.

9. GBD 2017 Risk Factor Collaborators. Erratum: Global, regional, and national comparative risk assessment of 84 behavioral, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392 (10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736 (18) 32225-6)). The Lancet 2019; 393(10190), e44.

10. Shere A, Eletta O, Goyal H. Circulating blood biomarkers in essential hypertension: a literature review. J Lab Precis Med 2017; 2: 99.

11. Xue Y, Iqbal N, Chan J, Maisel A. Biomarkers in hypertension and their relationship with myocardial target-organ damage. Curr Hypertens Rep 2014; 16(12): 502.

12. Wang TJ, Gona P, Larson MG, et al. Multiple biomarkers and the risk of incident hypertension. Hypertension 2007; 49(3): 432–438.

13. Liu CH. Anatomical, functional, and molecular biomarker applications of magnetic resonance neuroimaging. Future Neurol 2015; 10(1): 49–65.

14. Iacobellis G. Epicardial fat thickness as a biomarker in cardiovascular disease. Biomarkers in Cardiovascular Disease. Dordrecht: Springer 2013; 1-11.

15. Austys D, Dobrovolskij A, Jablonskiene V, Dobrovolskij V, Valeviciene N, Stukas, R. Epicardial Adipose Tissue Accumulation and Essential Hypertension in Non-Obese Adults. Medicina (Kaunas, Lithuania) 2019; 55(8): 456.

16. Blancas Sánchez IM, Aristizábal-Duque CH, Fernández Cabeza J, et al. Role of obesity and blood pressure in epicardial adipose tissue thickness in children. Pediatr Res 2022; 10.1038/s41390-022-02022-x.

17. du Toit WL, Schutte AE, Gafane-Matemane LF, Kruger R, Mels CMC. The renin- angiotensin-system and left ventricular mass in young adults: the African-PREDICT study. Blood Press 2021; 30(2): 98-107.

18. Topuz M, Dogan A. The effect of epicardial adipose tissue thickness on left ventricular diastolic functions in patients with normal coronary arteries. Kardiol Pol 2017; 75(3): 196-203.

19. Guan B, Liu L, Li,X, et al. Association between epicardial adipose tissue and blood pressure: A systematic review and meta-analysis. Nutrition, metabolism, and cardiovascular diseases: NMCD 2021; 31(9): 2547–2556.

20. Dicker D, Atar E, Kornowski, R, Bachar GN. Increased epicardial adipose tissue thickness as a predictor for hypertension: a cross-sectional observational study. J Clin Hypertens (Greenwich, Conn.) 2013; 15(12): 893–898.

21. Kim JS, Kim SW, Lee JS, et al. Association of pericardial adipose tissue with left ventricular structure and function: a region‐specific effect? Cardiovasc Diabetol 2021; 20(1): 1-9.

22. Devereux RB, Roman MJ. Left ventricular hypertrophy in hypertension: stimuli, patterns, and consequences. Hypertens Res 1999; 22(1): 1-9.

23. Peluso D, Badano LP, Muraru D, et al. Right atrial size and function assessed with three-dimensional and speckle-tracking echocardiography in 200 healthy volunteers. Eur Heart J Cardiovasc 2013; 14(11): 1106-1114.

24. Zoungas S, Asmar RP. Arterial stiffness and cardiovascular outcome. Clin Exp Pharmacol 2007; 34(7): 647-651.

25. Humphrey JD. Cardiovascular solid mechanics: cells, tissues, and organs. Springer Science & Business Media 2013.

26. Verma S, Siu SC. Aortic dilatation in patients with bicuspid aortic valve. N Engl J Med 2014; 370(20): 1920-1929.

27. Michelena HI, Khanna AD, Mahoney D. Incidence of aortic complications in patients with bicuspid aortic valves. JAMA 2011; 306(10): 1104-1112.

28. Mazurek T, Kiliszek M, Kobylecka M, et al. Relation of proinflammatory activity of epicardial adipose tissue to the occurrence of atrial fibrillation. Am J Cardiol 2014; 113(9): 1505-1508.

29. Baker AR, Da Silva NF, Quinn DW, et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol 2006; 5(1): 1-7.

30. Sengul C, Cevik C, Ozveren O, et al. Echocardiographic epicardial fat thickness is associated with carotid intima‐media thickness in patients with metabolic syndrome. Echocardiography 2011; 28(8): 853-858.